Publicacions
-
Hervás A, de Santos T, Quintero J, Ruíz-Lázaro PM, Alda JA, Fernández-Jaén A and Ramos-Quiroga JA.
Delphi Consensus on Attention Deficit Hyperactivity Disorder (ADHD): evaluation by a panel of experts
ACTAS ESPANOLAS DE PSIQUIATRIA . 44(6): 231-243. Nº de cites: 7
-
Alda JA, Muñoz D, Tor J, Merchán-Naranjo J, Tapia-Casellas C, Baeza I, Calvo-Escalona R, Castro-Fornieles J, Martínez-Cantarero C, Andrés-Nestares P, Fernández-Avilés F and Arango C.
Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY . 26(5): 449-457. Nº de cites: 4
-
Garcia-Amador M, Merchán-Naranjo J, Tapia C, Moreno C, Castro-Fornieles J, Baeza I, de la Serna E, Alda JA, Muñoz D, Andrés Nestares P, Cantarero CM and Arango C.
Neurological Adverse Effects of Antipsychotics in Children and Adolescents
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 35(6): 686-693. Nº de cites: 24
-
Sasot-Llevadot J, Ibáñez-Bordas RM, Soto-López A, Montañés-Rada F, Gastaminza-Pérez X, Alda JA, Cantó-Díez T, Catalá MA, Ferrin-Erdozáin M, García-Giral M, Graell-Bernal M, Granada-Jiménez O, Herreros-Rodríguez Ó, Mardomingo-Sanz MJ, Mojarro-Práxedes D, Morey-Canyelles J, Ortiz-Guerra J, Pàmies-Massana M, Rey-Sánchez F, Romera-Torrens M, Rubio-Morell B, Ruiz-Lázaro PM, Ruiz-Sanz F and Grupo de Especial Interés en el Trastorno por Déficit de Atención/Hiperactividad.
GEITDAH consensus on conduct disorders in children and adolescents
REVISTA DE NEUROLOGIA . 61(4): 167-182. Nº de cites: 2
-
Montañés-Rada, F., Gastaminza-Pérez, X., Catalá, M.A., Ruiz-Sanz, F., Ruiz-Lázaro, P.M., Herreros-Rodríguez, O., García-Giral, M., Ortiz-Guerra, J., Alda JA, Mojarro-Práxedes, D., Cantó-Díez, T., Mardomingo-Sanz, M.J., Sasot-Llevadot, J., Ibáñez-Bordas, R.M., Soto-López, A., Pàmies-Massana, M., Rey-Sánchez, F., Ferrin-Erdozáin, M., Graell-Bernal, M., Granada-Jiménez, O., Morey-Canyelles, J., Romera-Torrens, M. and Rubio-Morell, B..
GEITDAH consensus on conduct disorders in children and adolescents
REVISTA DE NEUROLOGIA . 61(4): 167-182.
-
Alda JA, Soutullo C, Ramos-Quiroga JA, Quintero J, Hervás A, Hernández-Otero I, Sans-Fitó A, Cardo-Jalón EC, Fernández-Jaén A, Fernández-Pérez M, Hidalgo-Vicario MI, Eddy-Ives LS and Sánchez J.
Expert recommendation: contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD).
ACTAS ESPANOLAS DE PSIQUIATRIA . 42 Suppl: 1-16. Nº de cites: 7
-
Arango C, Giráldez M, Merchán-Naranjo J, Baeza I, Castro-Fornieles J, Alda JA, Martínez-Cantarero C, Moreno C, de Andrés P, Cuerda C, de la Serna E, Correll CU, Fraguas D and Parellada M.
Second-generation antipsychotic use in children and adolescents: A six-month prospective cohort study in drug-naïve patients
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY . 53(11): 1179-11904. Nº de cites: 69
-
Baeza I, de la Serna E, Calvo-Escalona R, Morer A, Merchán-Naranjo J, Tapia C, Martínez-Cantarero MC, Andrés P, Alda JA, Sánchez B, Arango C and Castro-Fornieles J.
Antipsychotic use in children and adolescents: a 1-year follow-up study.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 34(5): 613-619. Nº de cites: 34
-
Montoya A, Quail D, Anand E, Cardo E, Alda JA and Escobar R.
Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.
ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS . 6(1): 25-34.
-
Alda JA and Serrano E.
Attention-Deficit Hyperactivity Disorder: Agreement between Clinical Impression and the SNAP-IV Screening Tool
ACTAS ESPANOLAS DE PSIQUIATRIA . 41(2): 76-83. Nº de cites: 18